Gene: CDH12
Official Full Name: cadherin 12provided by HGNC
Gene Summary: This gene encodes a type II classical cadherin of the cadherin superfamily. Alternative splicing of this gene results in multiple transcript variants. At least one of these variants encodes a preproprotein that is proteolytically processed to generate the mature cadherin protein. These integral membrane proteins mediate calcium-dependent cell-cell adhesion and are composed of a large N-terminal extracellular domain, a single membrane-spanning domain, and a small, highly conserved C-terminal cytoplasmic domain. Type II (atypical) cadherins are defined based on their lack of a histidine-alanine-valine (HAV) cell adhesion recognition sequence specific to type I cadherins. This particular cadherin appears to be expressed specifically in the brain and its temporal pattern of expression would be consistent with a role during a critical period of neuronal development, perhaps specifically during synaptogenesis. [provided by RefSeq, Nov 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38614 | CDH12 Knockout cell line (HeLa) | Human | CDH12 | 1:3~1:6 | Negative | Online Inquiry |
CDH12 Gene Knockout Cell Lines are genetically modified cell lines in which the CDH12 gene has been disrupted through targeted gene editing techniques, such as CRISPR-Cas9. These cell lines serve as vital tools for understanding the cellular and molecular mechanisms underpinning various biological processes, particularly those related to neural development and synaptic function. By creating models that lack this specific cell adhesion molecule, researchers can investigate the contributions of CDH12 to cellular communication, neurobiology, and associated pathologies.
Functionally, CDH12 plays a crucial role in the formation and maintenance of synaptic structures in the brain. It is involved in cell-cell adhesion processes that are essential for proper neuronal connectivity and signaling. By utilizing CDH12 knockout lines, scientists can delve into pathways involving synaptic plasticity, which are pivotal in learning and memory, as well as disorders such as autism spectrum disorder and schizophrenia. The elimination of CDH12 helps elucidate its impact on cellular behavior, offering insights into potential therapeutic targets.
The scientific importance of these cell lines extends to both research and clinical applications. For researchers, CDH12 knockout cell lines represent a powerful experimental model to explore disease mechanisms and drug responses in a controlled environment. They provide a platform for high-throughput screening of compounds aimed at modulating synaptic integrity, thereby advancing drug discovery efforts.
Compared to traditional methods of studying gene function, such as overexpression systems or the use of wild-type cell lines, CDH12 knockout cell lines allow for a more precise delineation of gene-specific effects. This specificity enhances experimental rigor and reliability in data interpretation, making these models particularly advantageous for genetic exploration.
In summary, CDH12 Gene Knockout Cell Lines are a valuable asset for researchers and clinicians searching for well-characterized models to dissect complex signaling pathways related to neuronal function and disease. Our company specializes in providing high-quality genetic tools, empowering the scientific community with innovative products designed to accelerate research and therapeutic discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.